What are the safety and efficacy outcomes of retatrutide in clinical trials?

Retatrutide demonstrates strong efficacy in reducing HbA1c levels and body weight in clinical trials, though common gastrointestinal adverse effects require careful monitoring. Its robust weight loss outcomes may offer a valuable option for patients with type 2 diabetes and obesity.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24283819
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What are the safety and efficacy outcomes of retatrutide in clinical trials?

Tripdatabase
1 links
Zenodo (CERN European Organization for Nuclear Research)
Diabetes Treatment and Management
article

What are the safety and efficacy outcomes of retatrutide in clinical trials?

Tripdatabase
article en

Abstract

Retatrutide demonstrates strong efficacy in reducing HbA1c levels and body weight in clinical trials, though common gastrointestinal adverse effects require careful monitoring. Its robust weight loss outcomes may offer a valuable option for patients with type 2 diabetes and obesity.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon